Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid cancer, Hurthle cell × motesanib diphosphate × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 1

Interventions

trametinib 1 spartalizumab 1 pembrolizumab 1 lenvatinib 1 gallium Ga 68 dotatate 1 dabrafenib 1 Sorafenib 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡